Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1366
First IPO Date
October 26, 2021
| Name | Title | Pay | Year Born |
| He Ping Hu | Director of the Institute of Chemical Drugs of Huiyu Pharmaceutical Research Institute | 0 | 1977 |
| Shou Jun Chen | Vice President of Pharmaceutical Research Institute | 0 | 1966 |
| Yong Chun Ren | Employee Representative Director & Deputy General Manager | 0 | 1968 |
| Yan Mei Yu | Accounting Supervisor | 0 | N/A |
| Tao Wei | Director of Institute of Innovative Biopharmaceuticals at Huiyu Pharmaceutical Research Institute | 0 | 1962 |
| Zhao Ding | Chairman of the Board & GM | 0 | 1985 |
| Chun Ping Zhang | Deputy GM, Secretary of the Board & Director | 0 | 1980 |
| Lan Gao | Director & Finance Director | 0 | 1971 |
| Gang Cai | Manager of Technical Department, Quality Manager & Quality Director | 0 | 1977 |
Sichuan Huiyu Pharmaceutical Co., Ltd., established in 2010 and headquartered in Neijiang, China, is actively involved in the entire pharmaceutical process. This includes the research, development, manufacturing, and commercialization of medications. The company's core specialization is in anti-tumor therapies and injectable drugs, catering primarily to the oncology sector and related medical disciplines, but also extending its offerings to other therapeutic areas.